EUVIMEDOpdag EUVIMED
Crossref

Baicalein Alleviates Cardiomyocyte Hypoxia Injury via ESR1‐Dependent Modulation of BAX/BCL‐XL Balance

Yu Xia iD, Xinyi Zhong iD, Chenggang Zhang

Phytochemical Analysis · 2026

DOI: 10.1002/pca.70069 ↗

At a glance

Journal article in Phytochemical Analysis, 2026. Written by Yu Xia and 2 co-authors. Institution: School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China. Major MEDLINE topics: Flavanones, Myocytes, Cardiac, bcl-2-Associated X Protein, Estrogen Receptor alpha. Cited 1 times so far (Crossref); 53 references. Funded by: Scientific Research Fund for High-level Talents of Beijing University of Chinese Medicine.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Hypoxia is a core pathological factor in myocardial injury and is involved in the development of various cardiovascular diseases. Although baicalein shows cardiovascular protective potential, its mechanism against hypoxic injury remains unclear.

Methods

H9c2 cardiomyocytes were exposed to sodium sulfite to establish a chemical hypoxia model. Network pharmacology, molecular docking, molecular dynamics simulation, and molecular biology assays were employed to predict the core target and investigate the underlying mechanism.

Results

Network pharmacology identified ESR1 as a core target, with stable binding to baicalein confirmed by molecular docking and dynamics simulations. Baicalein alleviated hypoxia‐induced oxidative stress by elevating key antioxidant markers and reducing malondialdehyde levels. It also ameliorated energy metabolism disorders, reduced lactate dehydrogenase release, suppressed reactive oxygen species production, and decreased cell apoptosis. Furthermore, baicalein upregulated hypoxia‐suppressed ESR1 protein expression and enhanced its co‑localization with the antiapoptotic protein BCL‐XL. The cytoprotective effects were abolished by the ESR1 inhibitor fulvestrant.

Conclusion

These findings demonstrate that baicalein protects cardiomyocytes against hypoxic injury through an ESR1‑dependent mechanism by modulating the BCL‑XL/BAX apoptotic balance, mitigating oxidative stress, and improving energy metabolism.

Subjects

MeSH terms (MEDLINE)

FlavanonesMyocytes, Cardiacbcl-2-Associated X ProteinEstrogen Receptor alphabcl-X ProteinAnimalsApoptosisRatsCell LineOxidative StressCell HypoxiaMolecular Docking SimulationReactive Oxygen SpeciesMolecular Dynamics SimulationAntioxidants

Author keywords

BCL‐XLESR1baicaleincardiomyocyte apoptosishypoxia

Substances

Flavanonesbaicaleinbcl-2-Associated X ProteinEstrogen Receptor alphabcl-X ProteinReactive Oxygen SpeciesAntioxidantsBax protein, rat

Authors and institutions

  • School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.

ORCID profiles: Yu Xia, Xinyi Zhong

Funding

  • Scientific Research Fund for High-level Talents of Beijing University of Chinese Medicine

Cite

APA

Xia, Y., Zhong, X., & Zhang, C. (2026). Baicalein Alleviates Cardiomyocyte Hypoxia Injury via ESR1‐Dependent Modulation of BAX/BCL‐XL Balance. Phytochemical Analysis. https://doi.org/10.1002/pca.70069

Vancouver

Xia Y, Zhong X, Zhang C. Baicalein Alleviates Cardiomyocyte Hypoxia Injury via ESR1‐Dependent Modulation of BAX/BCL‐XL Balance. Phytochemical Analysis. 2026. doi:10.1002/pca.70069

BibTeX
@article{Xia2026,
  author = {Xia, Yu and Zhong, Xinyi and Zhang, Chenggang},
  title = {Baicalein Alleviates Cardiomyocyte Hypoxia Injury via ESR1‐Dependent Modulation of BAX/BCL‐XL Balance},
  journal = {Phytochemical Analysis},
  year = {2026},
  doi = {10.1002/pca.70069}
}
Start for free →